Kevin Deane, MD, Ph.D

Associate Professor & Rheumatologist

Medical Advisor at imaware™

Experience

A variety of autoimmune diseases have a ‘preclinical’ period of development where blood or other tests can show abnormalities in the immune system sometimes years prior to someone feeling ‘sick’. Dr. Deane’s research is focused primarily on the preclinical rheumatoid arthritis (RA). Dr. Deane is currently a principal or co-investigator in several multi-centered studies investigating how genetics and environmental factors influence the early development of RA. He also has special interests in the role of the lung and other mucosal sites in the development of RA.​ Dr. Deane is also the Principal Investigator on an NIH-sponsored clinical trial for the prevention of RA that is entitled ‘Strategy for the Prevention of RA, or 'StopRA'.

Education

1987-1992: B.A. History University of California, Davis and Newbold College, Bracknell, Great Britain
1993-1997: M.D., Loma Linda University School of Medicine, Loma Linda, California
1997-2000: ​Intern and Resident, Internal Medicine, University of Colorado School of Medicine, Denver, Colorado
2001-2004: Fellow, Division of Rheumatology, University of Colorado School of Medicine, Denver, Colorado
2002-2011: Ph.D. Clinical Science, University of Colorado, School of Medicine, Aurora, CO

View Google Scholar profile

Expertise

  • Genetic & environmental factors of early RA development
  • Role of the lung & other mucosal sites in the development of RA
  • RA prevention
Kevin Deane, MD, Ph.D

Recommended By

Kevin Deane, MD, Ph.D

Articles Written By

Kevin Deane, MD, Ph.D

No items found.
Our content process